News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
614,832 Results
Type
Article (47375)
Company Profile (195)
Press Release (567262)
Multimedia
Podcasts (125)
Webinars (17)
Section
Business (172671)
Career Advice (2536)
Deals (31887)
Drug Delivery (125)
Drug Development (76338)
Employer Resources (160)
FDA (16336)
Job Trends (13315)
News (305677)
Policy (31963)
Tag
Academia (2376)
Academic (1)
Accelerated approval (14)
Adcomms (33)
Allergies (98)
Alliances (43475)
ALS (115)
Alzheimer's disease (1561)
Antibody-drug conjugate (ADC) (177)
Approvals (16284)
Artificial intelligence (331)
Autoimmune disease (35)
Automation (16)
Bankruptcy (325)
Best Places to Work (9919)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (98)
Bladder cancer (99)
Brain cancer (37)
Breast cancer (371)
Cancer (2913)
Cardiovascular disease (236)
Career advice (2127)
Career pathing (34)
CAR-T (184)
CDC (43)
Cell therapy (515)
Cervical cancer (23)
Clinical research (63060)
Collaboration (1004)
Company closure (3)
Compensation (724)
Complete response letters (37)
COVID-19 (2696)
CRISPR (61)
C-suite (349)
Cystic fibrosis (112)
Data (2988)
Decentralized trials (2)
Denatured (30)
Depression (80)
Diabetes (347)
Diagnostics (5624)
Digital health (20)
Diversity (6)
Diversity, equity & inclusion (43)
Drug discovery (142)
Drug pricing (152)
Drug shortages (35)
Duchenne muscular dystrophy (156)
Earnings (70130)
Editorial (50)
Employer branding (20)
Employer resources (144)
Events (93444)
Executive appointments (837)
FDA (18111)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (868)
Gene editing (133)
Generative AI (26)
Gene therapy (414)
GLP-1 (900)
Government (4113)
Grass and pollen (7)
Guidances (207)
Healthcare (15522)
HIV (42)
Huntington's disease (31)
IgA nephropathy (42)
Immunology and inflammation (187)
Immuno-oncology (13)
Indications (39)
Infectious disease (2885)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (69)
Intellectual property (120)
Interviews (465)
IPO (15173)
IRA (55)
Job creations (3767)
Job search strategy (1770)
Kidney cancer (14)
Labor market (51)
Layoffs (565)
Leadership (27)
Legal (7741)
Liver cancer (79)
Longevity (12)
Lung cancer (413)
Lymphoma (214)
Machine learning (11)
Management (54)
Manufacturing (434)
MASH (101)
Medical device (11558)
Medtech (11563)
Mergers & acquisitions (17444)
Metabolic disorders (924)
Multiple sclerosis (95)
NASH (23)
Neurodegenerative disease (147)
Neuropsychiatric disorders (46)
Neuroscience (2293)
NextGen: Class of 2025 (5284)
Non-profit (3334)
Now hiring (29)
Obesity (485)
Opinion (260)
Ovarian cancer (94)
Pain (120)
Pancreatic cancer (123)
Parkinson's disease (195)
Partnered (19)
Patents (320)
Patient recruitment (168)
Peanut (49)
People (51584)
Pharmaceutical (81)
Pharmacy benefit managers (25)
Phase I (18939)
Phase II (27455)
Phase III (21772)
Pipeline (1721)
Policy (248)
Postmarket research (2553)
Preclinical (7873)
Press Release (48)
Prostate cancer (151)
Psychedelics (44)
Radiopharmaceuticals (241)
Rare diseases (515)
Real estate (5218)
Recruiting (65)
Regulatory (22881)
Reports (37)
Research institute (2195)
Resumes & cover letters (417)
Rett syndrome (9)
RNA editing (10)
RSV (57)
Schizophrenia (102)
Series A (157)
Series B (103)
Service/supplier (10)
Sickle cell disease (67)
Special edition (20)
Spinal muscular atrophy (152)
Sponsored (36)
Startups (3258)
State (2)
Stomach cancer (17)
Supply chain (82)
Tariffs (71)
The Weekly (93)
Vaccines (894)
Venture capital (59)
Weight loss (329)
Women's health (42)
Worklife (20)
Date
Today (130)
Last 7 days (523)
Last 30 days (1749)
Last 365 days (30144)
2025 (17520)
2024 (33287)
2023 (37222)
2022 (47705)
2021 (51385)
2020 (48650)
2019 (39201)
2018 (29904)
2017 (30547)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (767)
Alabama (54)
Alaska (7)
Arizona (198)
Arkansas (11)
Asia (37777)
Australia (6169)
California (7260)
Canada (2097)
China (650)
Colorado (310)
Connecticut (338)
Delaware (201)
Europe (86453)
Florida (1126)
Georgia (231)
Hawaii (3)
Idaho (41)
Illinois (589)
India (30)
Indiana (319)
Iowa (18)
Japan (233)
Kansas (96)
Kentucky (27)
Louisiana (12)
Maine (65)
Maryland (1017)
Massachusetts (5471)
Michigan (212)
Minnesota (402)
Mississippi (3)
Missouri (83)
Montana (17)
Nebraska (22)
Nevada (75)
New Hampshire (58)
New Jersey (2065)
New Mexico (16)
New York (1980)
North Carolina (1087)
North Dakota (7)
Northern California (3241)
Ohio (202)
Oklahoma (11)
Oregon (31)
Pennsylvania (1527)
Puerto Rico (11)
Rhode Island (25)
South America (1138)
South Carolina (33)
South Dakota (1)
Southern California (2743)
Tennessee (117)
Texas (1058)
United States (26676)
Utah (186)
Virginia (189)
Washington D.C. (71)
Washington State (606)
West Virginia (4)
Wisconsin (72)
614,832 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Press Releases
Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
February 26, 2025
·
3 min read
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series
July 16, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease
July 16, 2025
·
10 min read
Press Releases
Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance
Agreement covers contract development and manufacturing of lead compound PH-762
July 25, 2025
·
4 min read
Press Releases
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
July 15, 2025
·
8 min read
Press Releases
JCR Pharmaceuticals Selected for Japan’s Regenerative Medicine CDMO Subsidy Program
July 17, 2025
·
4 min read
Podcast
Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 Earnings
Sarepta’s Elevidys is back on the market for ambulatory patients with Duchenne muscular dystrophy, Health Secretary Robert F. Kennedy Jr. reportedly plans to dissolve the U.S. Preventive Services Task Force and “fix” the vaccine injury compensation program, Merck, AstraZeneca and more report Q2 earnings, Novo names a new leader and Roche’s trontinemab impresses at AAIC25.
July 30, 2025
·
2 min read
·
Heather McKenzie
Manufacturing
Amid Trump’s Trade War, Some Drugmakers Stockpile Products in U.S.
Imports of pharmaceutical products surged in March, most of which came from Ireland, historically one of the biggest exporters of medicines to the U.S.
May 7, 2025
·
2 min read
·
Tristan Manalac
1 of 61,484
Next
